Post

Avatar
Cornelius J @jcornelius.bsky.social · 14 days
www.nih.gov/news-events/... "A Phase 1 trial testing the safety of an experimental nasal vaccine that may provide enhanced breadth of protection against emerging variants of SARS-CoV-2, the virus that causes COVID-19, is now enrolling healthy adults at three sites in the United States."
NIH-sponsored trial of nasal COVID-19 vaccine openswww.nih.gov Candidate vaccine could provide enhanced breadth of protection against emerging SARS-CoV-2 variants.